Curaleaf removes CBD health claims from website and social media after FDA warning
Curaleaf's letter from the FDA serves as a warning for other companies in the cannabis space to hold off on developing and launching CBD-focused product lines until the FDA releases an official set of rules.
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• August 7, 2019
Load More Stories